DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin

被引:67
作者
Maecker, HT [1 ]
Umetsu, DT [1 ]
DeKruyff, RH [1 ]
Levy, S [1 ]
机构
[1] STANFORD UNIV,MED CTR,DEPT PEDIAT,STANFORD,CA 94305
关键词
Th1/Th2; DNA vaccination; CTL;
D O I
10.1016/S0264-410X(97)00088-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
DNA vaccination may work through direct transfection of antigen presenting cells (APC), or by secretion of the encoded protein by muscle or skin cells for uptake by APC. If cytokines are attached to the antigen, they may influence APC or responding T cells to drive the response toward a Th1 or Th2 direction, and/or potentiate it in an antigen-specific manner. To test this concept, expression vectors were constructed containing the ovalbumin (OVA) gene either alone, or linked to cytokine genes including GM-CSF, IFN-gamma, IL-2, IL-4, IL-12, or a sequence encoding nine amino acids of IL-1 beta. These constructs expressed OVA-cytokine fusion proteins in vitro which retained cytokine bioactivity. C57BL/6 mice were injected intramuscularly with the DNA constructs. Little if any OVA-specific antibody was produced in response to any of the DNA constructs, except for OVA-IL-4. However, lymphocytes from BALB/c mice vaccinated with OVA-IL-12 and OVA-IL-1 beta constructs produced more IFN-gamma and less IL-4 during in vitro restimulation assays than did other groups. All constructs elicited OVA-specific cytotoxic responses which were maintained or even increased over 16 weeks. The OVA-IL-12 and OVA-IL-1 beta peptide constructs elicited the strongest cytotoxic responses at 2 weeks postinjection. Cytotoxic responses were seen in all animals, even those lacking OVA-specific Ab, and were not related to Ab level. These studies indicate that the humoral, cytokine, and cytotoxic responses to DNA vaccination can be effectively altered by certain cytokine fusion constructs. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:1687 / 1696
页数:10
相关论文
共 43 条
[1]   ADJUVANTS - CURRENT STATUS, CLINICAL PERSPECTIVES AND FUTURE-PROSPECTS (REPRINTED FROM TRENDS IN PHARMACOLOGICAL SCIENCES, VOL 14, PG 174-178, 1993) [J].
AUDIBERT, FM ;
LISE, LD .
IMMUNOLOGY TODAY, 1993, 14 (06) :281-284
[2]  
BECKERS W, 1993, J IMMUNOL, V151, P1757
[3]  
BORASCHI D, 1995, J IMMUNOL, V155, P4719
[4]   Nucleic acid vaccination against virally induced tumors [J].
Bright, RK ;
Shearer, MH ;
Kennedy, RC .
DNA VACCINES: A NEW ERA IN VACCINOLOGY, 1995, 772 :241-251
[5]   PROTECTION AGAINST LETHAL LYMPHOCYTIC CHORIOMENINGITIS VIRUS (LCMV) INFECTION BY IMMUNIZATION OF MICE WITH AN INFLUENZA-VIRUS CONTAINING AN LCMV EPITOPE RECOGNIZED BY CYTOTOXIC T-LYMPHOCYTES [J].
CASTRUCCI, MR ;
HOU, S ;
DOHERTY, PC ;
KAWAOKA, Y .
JOURNAL OF VIROLOGY, 1994, 68 (06) :3486-3490
[6]  
CHEN TT, 1994, J IMMUNOL, V153, P4775
[7]   A T(H)1-]T(H)2 SWITCH IS A CRITICAL STEP IN THE ETIOLOGY OF HIV-INFECTION [J].
CLERICI, M ;
SHEARER, GM .
IMMUNOLOGY TODAY, 1993, 14 (03) :107-110
[8]  
COLIGAN JE, 1995, CURRENT PROTOCOLS
[9]   DIRECT GENE-TRANSFER INTO MUSCLE [J].
DANKO, I ;
WOLFF, JA .
VACCINE, 1994, 12 (16) :1499-1502
[10]   DNA-MEDIATED IMMUNIZATION IN MICE INDUCES A POTENT MHC CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTE RESPONSE TO THE HEPATITIS-B ENVELOPE PROTEIN [J].
DAVIS, HL ;
SCHIRMBECK, R ;
REIMANN, J ;
WHALEN, RG .
HUMAN GENE THERAPY, 1995, 6 (11) :1447-1456